Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

被引：3

作者：

Eltayb, A ^{[1
]}

Svensson, TH ^{[1
]}

Ahlenius, S ^{[1
]}

机构：

[1] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2001年 / 411卷 / 03期

关键词：

5-HT1A receptors; 5-HT; (5-hydroxytrypytamine; serotonin) reuptake inhibitor; selective; catalepsy; (Rat);

D O I：

10.1016/S0014-2999(00)00924-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Neither a high dose of the selective serotonin reuptake inhibitor citalopram (100 mu mol kg(-1) s.c.), nor the 5-HT1A receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperaziny]-N-ethyl]-N-(2-pyridinyl) cyclohexane carboxamide 3HCl (WAY 100635) (0.1-0.4 mu mol kg(-1) s.c.) produced any evidence of catalepsy in adult male rats. When combined with citalopram, however. WAY 100635 produced a dose-dependent, and statistically significant, catalepsy in the inclined grid test. (C) 2001 Elsevier Science B.V. All rights reserved.

引用

页码：275 / 277

页数：3

共 50 条

[21] WAY-100635, an antagonist of 5-HT1A receptor, causes malformations of the CNS in ascidian embryos
Pennati, R
Groppelli, S
Sotgia, C
Zega, G
Pestarino, M
De Bernardi, F
[J]. DEVELOPMENT GENES AND EVOLUTION, 2003, 213 (04) : 187 - 192
[22] QUANTITATIVE AUTORADIOGRAPHIC CHARACTERIZATION OF THE BINDING OF [H-3] WAY-100635, A SELECTIVE 5-HT1A RECEPTOR ANTAGONIST
KHAWAJA, X
[J]. BRAIN RESEARCH, 1995, 673 (02) : 217 - 225
[23] The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors
Cosi, C
Koek, W
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (01) : 9 - 15
[24] The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset
Harder, JA
Maclean, CJ
Alder, JT
Francis, PT
Ridley, RM
[J]. PSYCHOPHARMACOLOGY, 1996, 127 (03) : 245 - 254
[25] EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST WAY-100635 ON HIPPOCAMPAL 5-HT RELEASE IN-VIVO
GURLING, J
ASHWORTHPREECE, MA
DOURISH, CT
ROUTLEDGE, C
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U152 - U152
[26] THE EFFECTS OF WAY-100635, A POTENT AND SELECTIVE 5-HT1A RECEPTOR ANTAGONIST, ON FEEDING AND 8-OH-DPAT-INDUCED FEEDING IN THE RAT
HARTLEY, JE
FORSTER, EA
FLETCHER, A
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U151 - U151
[27] Electrophysiological Assessment of Accelerated 5-HT1A Autoreceptor Desensitization in Rats Produced by Vilazodone, a Novel Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist
Ashby, Charles R.
Kehne, John H.
Bartoszyk, Gerd D.
Pierz, Kerri A.
Renda, Matthew J.
Athanasiou, Maria A.
[J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 237S - 238S
[28] Trazodone Acts as a Serotonin (5-HT) Reuptake Inhibitor and 5-HT1A Receptor Agonist on the 5-HT System
Ghanbari, Ramez
El Mansari, Mostafa
Blier, Pierre
[J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 242S - 242S
[29] The 5-HT1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task
Pitsikas, N
Rigamonti, AE
Cella, SG
Muller, EE
[J]. BRAIN RESEARCH, 2003, 983 (1-2) : 215 - 222
[30] Vilazodone, a Selective Serotonin Reuptake Inhibitor with Diminished Impact on Methylphenidate-Induced Gene Regulation in the Striatum: Role of 5-HT1A Receptor
Michael Hrabak
Connor Moon
Carlos A. Bolaños-Guzmán
Heinz Steiner
[J]. Molecular Neurobiology, 2024, 61 : 1907 - 1919

← 1 2 3 4 5 →